Tara Gelb - Publications

Affiliations: 
2010-2015 Pharmacology Georgetown University, Washington, DC 

8 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Hill NT, Gelb T, Urban D, Kellenberger T, Hall M, Brownell I. Abstract 575: Disulfiram plus copper synergizes with etoposide for the treatment of Merkel cell carcinoma Cancer Research. 80: 575-575. DOI: 10.1158/1538-7445.Am2020-575  0.32
2017 Carroll TM, Williams JS, Daily K, Rogers T, Gelb T, Coxon A, Wang SQ, Crago AM, Busam KJ, Brownell I. Hedgehog signaling inhibitors fail to reduce Merkel cell carcinoma viability. The Journal of Investigative Dermatology. PMID 28130073 DOI: 10.1016/J.Jid.2017.01.008  0.322
2015 Gelb T, Pshenichkin S, Hathaway HA, Grajkowska E, Dalley CB, Wolfe BB, Wroblewski JT. Atypical signaling of metabotropic glutamate receptor 1 in human melanoma cells. Biochemical Pharmacology. 98: 182-9. PMID 26291396 DOI: 10.1016/J.Bcp.2015.08.091  0.827
2015 Hathaway HA, Pshenichkin S, Grajkowska E, Gelb T, Emery AC, Wolfe BB, Wroblewski JT. Pharmacological characterization of mGlu1 receptors in cerebellar granule cells reveals biased agonism. Neuropharmacology. 93: 199-208. PMID 25700650 DOI: 10.1016/J.Neuropharm.2015.02.007  0.743
2015 Gelb T, Pshenichkin S, Rodriguez OC, Hathaway HA, Grajkowska E, DiRaddo JO, Wroblewska B, Yasuda RP, Albanese C, Wolfe BB, Wroblewski JT. Metabotropic glutamate receptor 1 acts as a dependence receptor creating a requirement for glutamate to sustain the viability and growth of human melanomas. Oncogene. 34: 2711-20. PMID 25065592 DOI: 10.1038/Onc.2014.231  0.715
2015 Gelb T, Pshenichkin S, Hathaway HA, Grajkowska E, Wolfe BB, Wroblewski JT. Abstract A15: mGlu1 Receptors and downstream signal transduction proteins as therapeutic targets for the treatment of metastatic melanoma Cancer Research. 75. DOI: 10.1158/1538-7445.Mel2014-A15  0.818
2014 Gelb T, Hathaway HA, Wroblewski JT. Triple threat treatment: Exploiting the dependence receptor properties of metabotropic glutamate receptor 1 against melanoma. Molecular & Cellular Oncology. 1: e969163. PMID 27308372 DOI: 10.4161/23723548.2014.969163  0.817
2013 DiRaddo JO, Pshenichkin S, Gelb T, Wroblewski JT. Two newly identified exons in human GRM1 express a novel splice variant of metabotropic glutamate 1 receptor. Gene. 519: 367-73. PMID 23481697 DOI: 10.1016/J.Gene.2013.02.009  0.772
Show low-probability matches.